Clinical Trial Update: A Study of the ILB-3101 in Patients with Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update notes that Innolake Biopharm is recruiting for a Phase 1 study of ILB-3101 in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ILB-3101

Snippet

Sponsor: Innolake Biopharm | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING